Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Donabedian
AddedMar 31, 2024
UpdatedMay 31, 2026
David Donabedian

David Donabedian

CEO, Longwood Fund

CrunchbaseLinkedIn

David Donabedian's Career

Longwood Fund
Longwood Fund

Boston, MA, US

CEO· C-Suite · Management
Anuncia
Anuncia

Scottsdale, AZ, US

Board Member· Board
Axial Therapeutics
Axial Therapeutics

Woburn, MA, US

Co-Founder & CEO· C-Suite · Management
Alcyone Lifesciences
Alcyone Lifesciences

Lowell, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Donabedian's Career

Longwood Fund
Longwood Fund
Investment FirmInvestment Firm202010Boston, MA, US
CEO· C-Suite · Management

Leadership at Longwood Fund

Paul SchimmelPaul SchimmelBoard Member
Michelle DippMichelle DippCo-Founder
Christoph WestphalChristoph WestphalCo-Founder
RICHARD H. ALDRICHRICHARD H. ALDRICHCo-Founder
Chris WalshChris WalshBoard Member

Similar to Longwood Fund

Longitude CapitalLongitude CapitalMenlo Park, CA, USest. 2006Longitude CapitalMenlo Park, CA, US · est. 2006

Longitude Capital: A venture capital firm investing in biotech, medtech, and health solutions for improved life quality.

Investment Firm45
Longevity Vision FundLongevity Vision FundNew York City, NY, USest. 2019Longevity Vision FundNew York City, NY, US · est. 2019

LVF: A venture capital fund investing in disruptive healthcare technologies for longer, healthier lives.

Investment Firm15
The Longevity FundThe Longevity FundSan Francisco, CA, USest. 2011The Longevity FundSan Francisco, CA, US · est. 2011

Longevity Fund: Investing in human longevity through innovative investment solutions.

Investment Firm2
Longwood Capital PartnersLongwood Capital PartnersPortola Valley, CA, USLongwood Capital PartnersPortola Valley, CA, US

Longwood Capital Partners: Financial services in Portola Valley, CA

Investment Firm5
Anuncia
Anuncia
Seed$1k352018Scottsdale, AZ, US
Board Member· Board

Leadership at Anuncia

Rich UptonRich UptonBoard Member
PJ AnandPJ AnandBoard Member
Elsa Chi AbruzzoElsa Chi AbruzzoBoard Member

Similar to Anuncia

CereVascCereVascAuburndale, FL, USMedical Devicesest. 2014CereVascAuburndale, FL, US · est. 2014

CereVasc, a medical device company, innovates minimally invasive treatments for neurological diseases.

Series A · $44M14
Anutra MedicalAnutra MedicalMorrisville, NC, USMedical Devicesest. 2015Anutra MedicalMorrisville, NC, US · est. 2015

Anutra Medical, Inc.: A North Carolina-based medical device company offering safe, efficient anesthetic dispensing solutions.

Pre-Seed · $3.3M12
BrainSpaceBrainSpaceBothell, WA, USMedical Devicesest. 2021BrainSpaceBothell, WA, US · est. 2021

BrainSpace: Collaborating to eliminate long-term handicaps from brain injuries.

Seed · $5.2M9
AnnoviantAnnoviantAlpharetta, GA, USMedical Devicesest. 2018AnnoviantAlpharetta, GA, US · est. 2018

Annoviant: Innovating healthcare with advanced medical technology development.

Seed · $1.9M30
Axial Therapeutics
Axial Therapeutics
Series C$110.9M292016Woburn, MA, US
Co-Founder & CEO· C-Suite · Management

Leadership at Axial Therapeutics

Ron RenaudRon RenaudBoard Member
Jim BlairJim BlairBoard Member
Sakae AsanumaSakae AsanumaBoard Member
Elaine HsiaoElaine HsiaoCo-Founder
Jeffrey YoungJeffrey YoungCo-Founder
Eric De La FortelleEric De La FortelleBoard Member
Alcyone Lifesciences
Alcyone Lifesciences
Series B$38.6M382010Lowell, MA, US
Board Member· Board

Leadership at Alcyone Lifesciences

Steve OesterleSteve OesterleBoard Member
Edgar JannottaEdgar JannottaBoard Member

David Donabedian's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to David Donabedian

Corey McCannCorey McCannCo-Founder · Pear TherapeuticsRanjit BindraRanjit BindraCo-Founder · Helix TherapeuticsAbhinay KondamreddyAbhinay KondamreddyCo-Founder · AlchemyDavid LaneDavid LaneFounder · Bio Green Med SolutionVijay PandeVijay PandeBoard Member · Schrödinger